Insights

Pharmacogenetics Leader Genelex is an established pioneer in pharmacogenetic testing and interpretation, with a long history dating back to 1987 and a patented decision support tool YouScript. This positions them as a trusted partner for healthcare providers seeking precision medication management and safer prescribing, suggesting sales opportunities in expanded lab services, CLIA-compliant testing, and integration with electronic health records.

Polypharmacy Focus With emphasis on polypharmacy patients at high risk of adverse drug events, there is a clear angle to offer tools and services that integrate pharmacogenetic data into multi-drug regimens, including medication reconciliation, risk assessment analytics, and decision support for clinicians managing complex patient profiles.

Clinical and Research Partnerships Genelex provides both clinical and research-level pharmacogenetic testing for CROs and pharmaceutical companies, signaling opportunities to collaborate on clinical trials, post-market surveillance, and drug development programs that require pharmacogenomic insights to ensure safer, more effective products.

Strategic Growth Opportunities Revenue is in the multi-million range with a lean employee base, indicating potential for scalable partnerships with mid-market healthcare systems, specialty clinics, and telemedicine platforms seeking to add pharmacogenetic testing capabilities without large-scale overhead.

Data and Compliance Enablement The tech stack includes cloud and analytics tools plus privacy and consent platforms (OneTrust, Cookiebot), suggesting readiness for integrations with health IT systems, data governance workflows, and patient consent management—areas ripe for upsell to healthcare networks prioritizing data security and interoperability.

Similar companies to Genelex

Genelex Tech Stack

Genelex uses 8 technology products and services including Amplitude, Crazy Egg, Hotjar, and more. Explore Genelex's tech stack below.

Genelex's Email Address Formats

Genelex uses at least 4 email formats:
Genelex Email FormatsExamplePercentage
First@genelex.comJohn@genelex.com
74%
FLast@genelex.comJDoe@genelex.com
13%
FirstLast@genelex.comJohnDoe@genelex.com
7%
FirstL@genelex.comJohnD@genelex.com
6%

Frequently Asked Questions

What is Genelex's phone number?

Minus sign iconPlus sign icon
You can contact Genelex's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Genelex's official website and social media links?

Minus sign iconPlus sign icon
Genelex's official website is genelex.com and has social profiles on LinkedIn.

How much revenue does Genelex generate?

Minus sign iconPlus sign icon
As of October 2026, Genelex's annual revenue is estimated to be $10M - $25M.

What is Genelex's SIC code and NAICS code?

Minus sign iconPlus sign icon
Genelex's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Genelex have currently?

Minus sign iconPlus sign icon
As of October 2026, Genelex has approximately 24 employees across 3 continents, including North America, Asia and Europe. Key team members include Vice President Sales: W. O., President New Business Development: B. B. and Partner: J. P. Explore Genelex's employee directory with LeadIQ.

What industry does Genelex belong to?

Minus sign iconPlus sign icon
Genelex operates in the Biotechnology Research industry.

What technology does Genelex use?

Minus sign iconPlus sign icon
Genelex's tech stack includes Amplitude, Crazy Egg, Hotjar, Amazon Web Services, Contentful, Cookiebot, OneTrust and Marketo.

What is Genelex's email format?

Minus sign iconPlus sign icon
Genelex's email format typically follows the pattern of First@genelex.com. Find more Genelex email formats with LeadIQ.

When was Genelex founded?

Minus sign iconPlus sign icon
Genelex was founded in 1987.
Genelex logo

Genelex

Biotechnology ResearchWashington, United States11-50 Employees

Genelex is a Seattle-based biotechnology research company founded in 1987 that focuses on pharmacogenetics and precision medication management. It provides pharmacogenetic testing and interpretation, supported by a proprietary clinical decision support tool, YouScript, to help clinicians tailor drug choices and dosages to an individual’s genetic profile. The firm notes that genetic variation influences how most people process medications, which can lead to different responses to the same dose and contribute to adverse drug events. 

Genelex serves physicians managing patients with polypharmacy and also provides testing to CROs and pharmaceutical companies for clinical and research applications, supporting safer drug development and use. With a long-standing presence in pharmacogenetics, the company is positioned as a leader in its field. A noted development in its history is a partnership with the Coalition Against Pediatric Pain announced in 2014.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1987
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Genelex's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.